Category Science and Technology
Will Hatfield suggests that, in Canada, persons born from gametes or embryos that have been genetically modified would be members of a new class of humans, and potentially in need of specific legal protections.
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
Diane Tober considers how different compensation schemes for donation affect the experiences and choices of egg donors and announces the launch of her research project which analyzes egg donation practices in the US and Spain.
Art Leader critiques the Assisted Human Reproduction Act draft regulations and maintains that the Act fails to address societal challenges relating to emerging reproductive science.
Kathy Hodgkinson and Daryl Pullman propose that high risk/high recurrence genetic diseases should come under the purview of public health.
Françoise Baylis responds to the recently announced birth of the world’s first genome edited babies and raises concerns about the scientific practice and ethical accountability.
Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.